- Report
- January 2026
- 195 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- September 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- October 2024
- 270 Pages
China
From €3503EUR$4,000USD£3,041GBP
- Report
- October 2024
- 135 Pages
China
From €1576EUR$1,800USD£1,368GBP
Cefdinir is an antibiotic used to treat a variety of bacterial infections. It belongs to the cephalosporin class of antibiotics, which are used to treat a wide range of bacterial infections. Cefdinir is used to treat infections caused by bacteria, such as bronchitis, pneumonia, ear infections, skin infections, and urinary tract infections. It is also used to treat certain sexually transmitted diseases. Cefdinir is available in both oral and intravenous forms.
Cefdinir is a widely used antibiotic in the treatment of bacterial infections. It is generally well tolerated and has a low risk of side effects. It is also relatively inexpensive compared to other antibiotics. Cefdinir is often prescribed as a first-line treatment for bacterial infections, as it is effective against a wide range of bacteria.
The cefdinir market is highly competitive, with many companies offering cefdinir products. Some of the major companies in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. Show Less Read more